Participants

In order to know who you will be able to meet during this day we provide a bio sketch and information on research focus of all participants here.

 

Gunter Kenis | Maastricht University
Omics (proteome, transcriptome, (epi)genome) - In-vitro models
Psychoneuroimmunology, Induced pluripotent stem cells, Epigenetics mechanisms, genomics, Gene-environment interactions

My research focuses on mechanisms of gene-environment interactions in the context of psychiatric and neurodegenerative disorders. Discoveries from several of our cohort studies yielded candidate pathways that are now being examined and validated at molecular level. For this, we are currently establishing patient-derived in-vitro models of stress-related disorders and Alzheimer’s Disease. Secondly, I am passionate about mind-body relationships, in particular the impact of peripheral inflammation on brain function. Here, we currently investigate the role of the tryptophan-kynurenine pathway as mediators in these processes, and how inflammation-induced activation of this pathway contributes to affective and cognitive deterioration in Alzheimer’s Disease.
Publications

Rudy Schreiber| Maastricht University
Major depression, transdiagnostic; RDoC; serotonin

Rudy Schreiber got his B.S. in Medicinal Biology and his Ph.D. in Neuropharmacology from the University of Groningen in the Netherlands. He started his career in central nervous system drug discovery in 1993. Subsequently he progressed from bench scientist to senior leadership roles at global pharmaceutical companies, including Servier (France), Bayer (Germany), Roche (CA) and Sepracor (currently, Sumitomo Pharma America, Inc, MA). From 2010 till 2012 he was the SVP of the Neurobiology group of the contract research organization, Evotec (Germany). Rudy’s drug discovery experience covers a wide range of psychiatric and neurologic indications. He also worked with many different classes of molecular targets and led projects ranging from the idea stage throughout proof of principle testing. He has published more than 100 papers and 30 patents. In 2012, he founded Suadeo Drug Discovery Consulting LLC in Boston. Rudy joined Maastricht University in 2018 and is coordinator of the 2-year research master program Drug Development and NeuroHealth. After this career change, he (re)discovered his interest for education, especially for training the next generation of drug hunters and neuro-entrepreneurs. Rudy is a Homo Aquaticus who lives on a boat in Maastricht Marina and spends his free time rowing on the Maas River or sailing offshore.
Publications